Technology

Pipeline

Divider text here

VitamFero has currently established conceptual proof for two candidate vaccines (i.e. VFOtx-251 and VFOne-273) that aim to combat ovine toxoplasmosis and bovine neosporosis. Two other products (i.e. VFOlh-211 in particular) that aim to prevent canine leishmaniasis and equine protozoal myeloencephalitis are at an earlier development stage.

Full 1

VitamFero is also investing in the neonatal immunostimulant segment, having produced initial conceptual proof relating to bovine cryptosporidiosis.

Full 2

AMAZING FEATURES

Divider text here
Praesent turpis tortor, posuere at nisl at, tincidunt condimentum ligula. Fusce purus tortor, ornare quis lectus eu, lacinia faucibus lorem. Aenean ac mi elementum libero semper porttitor. Aenean in dui ut urna feugiat suscipit at vel dolor.
Curabitur sit amet lorem et nunc varius sodales nec et leo. Vivamus sagittis turpis vel nisl facilisis, sed placerat odio ultricies. Suspendisse dolor lorem, faucibus eu tortor ac, hendrerit dapibus mi. Nam sed nunc ac magna
  • Aenean eget mi eget
  • Sed arcu eros lacinia
  • Duis dictum purus
  • Integer sodales justo
  • Etiam in sem et lectus
Curabitur sit amet lorem et nunc varius sodales nec et leo. Vivamus sagittis turpis vel nisl facilisis, sed placerat odio ultricies. Suspendisse dolor lorem, faucibus eu tortor ac, hendrerit dapibus mi. Nam sed nunc ac magna